Nyxoah Announces Change to Board of Directors
Mont–Saint–Guibert, Belgium "" [...] Read more »
Nyxoah Announces Change to Board of Directors
Mont–Saint–Guibert, Belgium "" [...] Read more »
Nyxoah to Participate in the Jefferies London Healthcare Conference
Read more »
Nyxoah to Release Third Quarter Financial Results on November 8, 2022
[...] Read more »REGULATED INFORMATION
Mont–Saint–Guibert (Belgium), September 30, 2022, 10:30 pm CET / 4:30 pm ET "" In accordance with article [...] Read more »
Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference
Mont–Saint–Guibert, Belgium "" August 18, 2022, [...] Read more »
REGULATED INFORMATION
Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results
DREAM enrollment complete, [...] Read more »
Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test
Mont–Saint–Guibert, Belgium "" August 2, 2022, [...] Read more »
Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference
Mont–Saint–Guibert, Belgium "" July 27, 2022, 10:30pm CET / 4:30pm [...] Read more »
Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022
Mont–Saint–Guibert, Belgium "" July 19, 2022, 10:30pm CET / [...] Read more »
Nyxoah Announces CE Mark Approval for Genio 2.1
The next generation external activation chip leverages Nyxoah's scalable platform to continuously enhance patient [...] Read more »